+Search query
-Structure paper
Title | mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies. |
---|---|
Journal, issue, pages | Science, Vol. 384, Issue 6697, Page eadk0582, Year 2024 |
Publish date | May 17, 2024 |
Authors | Zhenfei Xie / Ying-Cing Lin / Jon M Steichen / Gabriel Ozorowski / Sven Kratochvil / Rashmi Ray / Jonathan L Torres / Alessia Liguori / Oleksandr Kalyuzhniy / Xuesong Wang / John E Warner / Stephanie R Weldon / Gordon A Dale / Kathrin H Kirsch / Usha Nair / Sabyasachi Baboo / Erik Georgeson / Yumiko Adachi / Michael Kubitz / Abigail M Jackson / Sara T Richey / Reid M Volk / Jeong Hyun Lee / Jolene K Diedrich / Thavaleak Prum / Samantha Falcone / Sunny Himansu / Andrea Carfi / John R Yates / James C Paulson / Devin Sok / Andrew B Ward / William R Schief / Facundo D Batista / |
PubMed Abstract | Germline-targeting (GT) HIV vaccine strategies are predicated on deriving broadly neutralizing antibodies (bnAbs) through multiple boost immunogens. However, as the recruitment of memory B cells ...Germline-targeting (GT) HIV vaccine strategies are predicated on deriving broadly neutralizing antibodies (bnAbs) through multiple boost immunogens. However, as the recruitment of memory B cells (MBCs) to germinal centers (GCs) is inefficient and may be derailed by serum antibody-induced epitope masking, driving further B cell receptor (BCR) modification in GC-experienced B cells after boosting poses a challenge. Using humanized immunoglobulin knockin mice, we found that GT protein trimer immunogen N332-GT5 could prime inferred-germline precursors to the V3-glycan-targeted bnAb BG18 and that B cells primed by N332-GT5 were effectively boosted by either of two novel protein immunogens designed to have minimum cross-reactivity with the off-target V1-binding responses. The delivery of the prime and boost immunogens as messenger RNA lipid nanoparticles (mRNA-LNPs) generated long-lasting GCs, somatic hypermutation, and affinity maturation and may be an effective tool in HIV vaccine development. |
External links | Science / PubMed:38753770 / PubMed Central |
Methods | EM (single particle) |
Resolution | 3.14 - 30.0 Å |
Structure data | EMDB-28937: N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 42 from protein immunized wild type mice EMDB-28938: N332-GT5 SOSIP in complex with V1V3 and base polyclonal Fabs isolated at day 16 from protein immunized BG18HCgl knock-in mice EMDB-28939: N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 42 from mRNA immunized wild type mice EMDB-28940: N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 16 from mRNA immunized BG18HCgl knock-in mice EMDB-28941, PDB-8f92: EMDB-28942, PDB-8f9g: EMDB-28945, PDB-8f9m: EMDB-29330: N332-GT5 SOSIP in complex with base polyclonal Fabs isolated at day 42 from protein immunized wild type mice EMDB-29333: N332-GT5 SOSIP in complex with base polyclonal Fabs isolated at day 42 from protein immunized BG18HCgl knock-in mice EMDB-29334: N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 16 from mRNA immunized wild type mice EMDB-29335: N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 42 from mRNA immunized BG18HCgl knock-in mice EMDB-43190, PDB-8vfv: EMDB-43191: N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 14 from N332-GT2 nanoparticle-immunized BG18HCgl knock-in mice EMDB-43192: N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 15 from N332-GT5 nanoparticle-immunized BG18HCgl knock-in mice |
Chemicals | ChemComp-NAG: |
Source |
|
Keywords | VIRAL PROTEIN/IMMUNE SYSTEM / mouse antibody / germline targeting / HIV-1 / vaccine design / VIRAL PROTEIN / VIRAL PROTEIN-IMMUNE SYSTEM complex / polyclonal |